Skip to main content

Centessa Pharmaceuticals plc

CNTADelisted Jun 24, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001847903

Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.

Q2 2021 vs. Q1 2021

How the institutions holding Centessa Pharmaceuticals plc changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of CNTA: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders050+50
Shares047.4M+47.4M
Value$0$1.05B+$1.05B

New holders (50)

Institutions that held Centessa Pharmaceuticals plc at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to CNTA in Q2 2021
InstitutionSharesValue% of portfolio
Medicxi Ventures Management (Jersey) Ltd17,923,892$398.1M71.34%
Janus Henderson Group PLC5,680,933$120.1M0.05%
Vida Ventures Advisors, LLC3,931,818$87.3M21.90%
Price T Rowe Associates Inc2,011,073$43.9M0.00%
Samsara BioCapital, LLC1,537,533$34.1M4.49%
General Atlantic LLC1,500,000$33.3M0.24%
Cormorant Asset Management, LP1,427,273$31.1M1.21%
Ra Capital Management, L.P.1,280,300$28.4M0.46%
VR Adviser, LLC1,127,272$25.0M3.04%
Wellington Management Group LLP1,106,577$24.6M0.00%
Driehaus Capital Management LLC999,861$22.2M0.29%
Logos Global Management LP939,545$20.9M1.79%
Franklin Resources Inc922,700$20.5M0.01%
Boxer Capital, LLC904,227$20.1M0.71%
Woodline Partners LP822,518$18.3M0.34%
FMR LLC790,000$17.5M0.00%
EcoR1 Capital, LLC754,545$16.8M0.63%
Millennium Management LLC548,452$12.2M0.02%
Avoro Capital Advisors LLC500,000$11.1M0.19%
Citadel Advisors LLC456,233$10.1M0.01%
Baker Bros. Advisors LP400,000$8.88M0.04%
American Century Companies Inc371,504$8.25M0.01%
Ensign Peak Advisors, Inc350,000$7.77M0.02%
Jennison Associates LLC300,000$6.66M0.00%
Monashee Investment Management LLC130,000$2.89M0.35%
Point72 Asset Management, L.P.100,000$2.22M0.01%
State of Wisconsin Investment Board80,381$1.78M0.00%
Affinity Asset Advisors, LLC66,957$1.49M0.71%
Caas Capital Management LP62,500$1.39M0.07%
BVF Inc58,900$1.31M0.05%
Tudor Investment Corp Et Al43,079$957.0K0.02%
Temasek Holdings (Private) Ltd41,680$926.0K0.00%
Blackstone Group Inc.40,000$888.0K0.00%
Squarepoint Ops LLC37,771$839.0K0.01%
Marshall Wace North America L.P.34,228$760.0K0.00%
TD Asset Management Inc33,252$686.0K0.00%
Ghisallo Capital Management LLC25,000$555.0K0.02%
Northern Trust Corp18,400$409.0K0.00%
Brookfield Asset Management Inc.18,404$409.0K0.00%
Two Sigma Investments, LP9,973$222.0K0.00%
Geode Capital Management, LLC9,513$211.0K0.00%
BlackRock Inc.4,992$110.0K0.00%
Bank of America Corp2,398$54.0K0.00%
JPMorgan Chase & Co2,090$47.0K0.00%
Citigroup Inc1,091$24.0K0.00%
Tower Research Capital LLC (TRC)1,077$24.0K0.00%
Pinz Capital Management, LP900$20.0K0.01%
UBS Group AG678$15.0K0.00%
Cubist Systematic Strategies, LLC400$9.00K0.00%
US Bancorp19$00.00%

Sold out (0)

Institutions that held Centessa Pharmaceuticals plc at the end of Q1 2021 and filed for Q2 2021 without it.

None.